References
- Chang YC , NagasueN, AbeS, TaniuraH, KumarDD, NakamuraT. Comparison between the clinicopathologic features of AFP-positive and AFP-negative gastric cancers. Am. J. Gastroenterol.87(3) , 321–325 (1992).
- Akiyama Y , WatkinsN, SuzukiH et al. GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer. Mol. Cell Biol.23(23) , 8429–8439 (2003).
- Wen XZ , AkiyamaY, PanKF et al. Methylation of GATA-4 and GATA-5 and development of sporadic gastric carcinomas. World J. Gastroenterol. 16(10) , 1201–1208 (2010).
- Yamamura N , KishimotoT. Epigenetic regulation of GATA4 expression by histone modification in AFP-producing gastric adenocarcinoma. Exp. Mol. Pathol.93(1) , 35–39 (2012).
References
- Varier RA , TimmersHT. Histone lysine methylation and demethylation pathways in cancer. Biochim. Biophys. Acta1815(1) , 75–89 (2011).
- Seligson DB , HorvathS, McBrianMA et al. Global levels of histone modifications predict prognosis in different cancers. Am. J. Pathol. 174(5) , 1619–1628 (2009).
- El-Serag HB , RudolphKL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology132(7) , 2557–2576 (2007).
- He C , XuJ, ZhangJ et al. High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma. Hum. Pathol. doi:10.1016/j.humpath.2011.11.003 (2012) (Epub ahead of print).